戻る Agenda
OS16 What is the Quality of Real World Evidence?
Session Chair(s)
Daisaku Sato, PHD, MPHARM, RPH
Councilor for Pharmaceutical Affairs, Ministry of Health, Labour and Welfare, Japan
Speaker(s)
Masao Iwagami, MD, PHD
Assistant Professor, Faculty of Medicine, University of Tsukuba, Japan
Hisashi Urushihara, DrPH
Professor, Faculty of Pharmacy, Department of Pharmacy, Keio University, Japan
Gerald Dal Pan, MD, MHS
Director, Office of Surveillance and Epidemiology, CDER, FDA, United States
Catherine Cohet, PHD
Senior Pharmacoepidemiologist, Data Analytics and Methods Task Force, European Medicines Agency, Netherlands